D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$454M |
| 2 |
Apple
AAPL
|
+$364M |
| 3 |
Procter & Gamble
PG
|
+$314M |
| 4 |
Verizon
VZ
|
+$308M |
| 5 |
Pfizer
PFE
|
+$299M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$735M |
| 2 |
Emerson Electric
EMR
|
+$423M |
| 3 |
Biogen
BIIB
|
+$354M |
| 4 |
PayPal
PYPL
|
+$349M |
| 5 |
Amazon
AMZN
|
+$338M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.77% |
| 2 | Healthcare | 11.58% |
| 3 | Consumer Discretionary | 8.97% |
| 4 | Financials | 7.64% |
| 5 | Communication Services | 5.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WIRE
3351
DELISTED
Encore Wire Corp
WIRE
| $321K | ﹤0.01% |
7,654
+1,733
| +29% | +$89.4K |
|
3352
Manitowoc
MTW
$516M
| $320K | ﹤0.01% |
37,593
+21,399
| +132% | +$279K |
|
|
MAXR
3353
CALL
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $320K | ﹤0.01% |
30,000
| – | – |
|
3354
Columbus McKinnon
CMCO
$465M
| $319K | ﹤0.01% |
12,762
-7,703
| -38% | -$256K |
|
|
GTLS
3355
PUT
DELISTED
Chart Industries
GTLS
| $319K | ﹤0.01% |
+11,000
| New | +$597K |
|
3356
Barings BDC
BBDC
$862M
| $318K | ﹤0.01% |
42,505
-55,052
| -56% | -$522K |
|
3357
Civeo
CVEO
$379M
| $318K | ﹤0.01% |
64,265
-47,620
| -43% | -$633K |
|
3358
PUT
Oneok
OKE
$58.7B
| $318K | ﹤0.01% |
+14,600
| New | +$890K |
|
|
CLR
3359
CALL
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $318K | ﹤0.01% |
41,600
+4,600
| +12% | +$103K |
|
3360
PUT
AGNC Investment
AGNC
$12.3B
| $317K | ﹤0.01% |
+30,000
| New | +$500K |
|
3361
PUT
Turning Point Brands
TPB
$1.47B
| $317K | ﹤0.01% |
+15,000
| New | +$351K |
|
3362
Brady Corp
BRC
$4.45B
| $316K | ﹤0.01% |
6,992
-25,789
| -79% | -$1.31M |
|
3363
PUT
Nutanix
NTNX
$14.9B
| $316K | ﹤0.01% |
20,000
-43,500
| -69% | -$1.22M |
|
3364
Ecovyst
ECVT
$1.36B
| $312K | ﹤0.01% |
+28,644
| New | +$398K |
|
3365
PUT
Nektar Therapeutics
NKTR
$2.39B
| $312K | ﹤0.01% |
1,167
| – | – |
|
|
AMRN
3366
Amarin Corp
AMRN
$284M
| $311K | ﹤0.01% |
3,885
-47,744
| -92% | -$15.9M |
|
|
CVGW
3367
DELISTED
Calavo Growers
CVGW
| $311K | ﹤0.01% |
5,384
-52,335
| -91% | -$3.7M |
|
3368
AC Immune
ACIU
$227M
| $310K | ﹤0.01% |
+44,914
| New | +$351K |
|
|
HTZ
3369
CALL
DELISTED
Hertz Global Holdings, Inc.
HTZ
| $309K | ﹤0.01% |
+50,000
| New | +$676K |
|
3370
CALL
Cooper-Standard Automotive
CPS
$504M
| $308K | ﹤0.01% |
30,000
| – | – |
|
3371
PUT
Fair Isaac
FICO
$28.7B
| $308K | ﹤0.01% |
1,000
-29,900
| -97% | -$11M |
|
3372
OrthoPediatrics
KIDS
$485M
| $307K | ﹤0.01% |
7,742
-5,324
| -41% | -$239K |
|
|
FLIC
3373
DELISTED
First of Long Island Corp
FLIC
| $306K | ﹤0.01% |
17,659
+4,251
| +32% | +$89K |
|
3374
Sony
SONY
$123B
| $305K | ﹤0.01% |
25,730
-11,305
| -31% | -$148K |
|
3375
PUT
Applied Optoelectronics
AAOI
$8.04B
| $304K | ﹤0.01% |
40,000
-26,800
| -40% | -$283K |
|
Similar funds
D.E. Shaw & Co's Q1 2020 Portfolio in Review
As of Q1 2020, D.E. Shaw & Co held 4,498 positions worth $64.1B, down 27% from $87.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
D.E. Shaw & Co withdrew a net $5.59B in Q1 2020, closing 626 positions and reducing 1,723 holdings. Its most notable exit was PG&E, an estimated $79M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, D.E. Shaw & Co opened a new position in iShares iBoxx $ Investment Grade Corporate Bond ETF worth $124M.
- D.E. Shaw & Co's largest Q1 2020 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 1,005,000 shares worth $124M.
- D.E. Shaw & Co added most to ExxonMobil in Q1 2020, an estimated $454M increase.
- D.E. Shaw & Co's biggest Q1 2020 reduction was Tesla, cutting an estimated $735M.
- D.E. Shaw & Co fully exited PG&E in Q1 2020, selling an estimated $79M.
- D.E. Shaw & Co's ten largest holdings make up 12% of its $64.1B portfolio in Q1 2020.
- D.E. Shaw & Co opened 538 new positions and closed 626 in Q1 2020.
- D.E. Shaw & Co's portfolio value fell 27% quarter-over-quarter to $64.1B.
Based on D.E. Shaw & Co's 13F filing for Q1 2020, filed 15 May 2020.